Literature DB >> 33245375

Endoscopic observation finding in the core decompression procedure of osteonecrosis of femoral head and effect of additional treatments.

Hyon Pak1, Song Gun Ri2, Myong Guk Jang2, Sung Jae Kim3.   

Abstract

PURPOSE: To observe necrotic findings of the femoral head through the endoscopic examination when performing the decompression procedure widely used in the treatment of osteonecrosis of femoral head. To assess the efficacy of injection of bone marrow aspirated from the iliac crest and new vascularized bone graft into the core of femoral head based on the endoscopic findings.
METHODS: The first stage of osteonecrosis of femoral head based on ARCO classification includes 23, second stage 36, and third stage eight femoral heads. Bone marrow transplantations have been performed in 49 hip joints and new vascularized bone grafts in 18 hip joints.
RESULTS: The endoscopic findings of osteonecrosis of femoral heads are varied, and they can be divided into five categories. The average time in core decompression and bone marrow injection was 15 minutes, and the average time of new pedicled bone grafts was 65 minutes (45-90 minutes). The efficacy of bone marrow injection was 93.88%, and the efficacy of vascularized bone graft was 94.44% when performed based on the endoscopic findings.
CONCLUSION: It is possible to increase the treatment efficacy of the osteonecrosis of the femoral head when appropriate additional treatments are applied based on endoscopic findings in the decompression procedures of pre-collapse osteonecrosis of the femoral head.

Entities:  

Keywords:  Bone grafts; Bone marrow; Endoscopic; Osteonecrosis

Year:  2020        PMID: 33245375     DOI: 10.1007/s00264-020-04863-9

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  7 in total

1.  Core decompression treatment of early-stage osteonecrosis of femoral head resulted from venous stasis or artery blood supply insufficiency.

Authors:  De-Wei Zhao; Xiao-Bing Yu
Journal:  J Surg Res       Date:  2014-12-11       Impact factor: 2.192

2.  Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial.

Authors:  Lu Cao; Changan Guo; Jifei Chen; Zenggan Chen; Zuoqin Yan
Journal:  Clin Orthop Relat Res       Date:  2017-05-04       Impact factor: 4.176

3.  Treatment of osteonecrosis of the femoral head with focal anatomic-resurfacing implantation (HemiCAP): preliminary results of an alternative option.

Authors:  Onur Bilge; Mahmut Nedim Doral; Mustafa Yel; Nazim Karalezli; Anthony Miniaci
Journal:  J Orthop Surg Res       Date:  2015-04-28       Impact factor: 2.359

4.  Risk factor analysis for postoperative complications requiring revision surgery after transtrochanteric rotational osteotomy for osteonecrosis of the femoral head.

Authors:  Kazuyuki Karasuyama; Goro Motomura; Satoshi Ikemura; Jun-Ichi Fukushi; Satoshi Hamai; Kazuhiko Sonoda; Yusuke Kubo; Takuaki Yamamoto; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2018-01-10       Impact factor: 2.359

5.  Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively.

Authors:  Yohei Tomaru; Tomokazu Yoshioka; Hisashi Sugaya; Katsuya Aoto; Hiroshi Wada; Hiroshi Akaogi; Masashi Yamazaki; Hajime Mishima
Journal:  BMC Musculoskelet Disord       Date:  2017-07-06       Impact factor: 2.362

6.  Clinical value of 3D printing guide plate in core decompression plus porous bioceramics rod placement for the treatment of early osteonecrosis of the femoral head.

Authors:  Bo Li; Pengfei Lei; Hao Liu; Xiaobin Tian; Ting Wen; Ruyin Hu; Yihe Hu
Journal:  J Orthop Surg Res       Date:  2018-05-30       Impact factor: 2.359

7.  Lantern-shaped screw loaded with autologous bone for treating osteonecrosis of the femoral head.

Authors:  Dasheng Lin; Lei Wang; Zhaoliang Yu; Deqing Luo; Xigui Zhang; Kejian Lian
Journal:  BMC Musculoskelet Disord       Date:  2018-09-05       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.